Publicaciones en colaboración con investigadores/as de Queen's University Belfast (7)

2019

  1. NAD(P)H quinone oxidoreductase (NQO1): An enzyme which needs just enough mobility, in just the right places

    Bioscience Reports, Vol. 39, Núm. 1

2018

  1. Improving the Activity and Stability of Human Galactokinase for Therapeutic and Biotechnological Applications

    ChemBioChem, Vol. 19, Núm. 10, pp. 1088-1095

2016

  1. Conformational dynamics is key to understanding loss-of-function of NQO1 cancer-associated polymorphisms and its correction by pharmacological ligands

    Scientific Reports, Vol. 6

  2. Galactokinase promiscuity: A question of flexibility?

    Biochemical Society Transactions, Vol. 44, pp. 116-122

  3. Natural small molecules as stabilizers and activators of cancer-associated NQO1 polymorphisms

    Current Drug Targets, Vol. 17, Núm. 13, pp. 1506-1514

2014

  1. FAD binding overcomes defects in activity and stability displayed by cancer-associated variants of human NQO1

    Biochimica et Biophysica Acta - Molecular Basis of Disease, Vol. 1842, Núm. 11, pp. 2163-2173

  2. The metastability of human UDP-galactose 4′-epimerase (GALE) is increased by variants associated with type III galactosemia but decreased by substrate and cofactor binding

    Archives of Biochemistry and Biophysics, Vol. 562, pp. 103-114